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Background: Fractional flow reserve (FFR) assessment of remote arteries, in the context of a 
bystander chronic total occlusion (CTO), can lead to false positive results. Adenosine stress 
cardiovascular magnetic resonance (CMR) evaluates perfusion defects across the entire 
myocardium and may therefore be a reliable tool in the work-up of remote lesions in CTO 
patients. The IMPACT-CTO study investigated donor artery invasive physiology before, 
immediately post, and at 4 months following right coronary artery (RCA) CTO percutaneous 
coronary intervention (PCI). The aim of this subanalysis was to assess the concordance 
between baseline perfusion CMR and serial FFR evaluation of left anterior descending artery 
(LAD) ischemia in patients from the IMPACT-CTO study. 
Methods: Baseline adenosine stress CMR examinations from 26 patients were analyzed for 
qualitative evidence of LAD ischemia. The results were correlated with the serial LAD FFR 
measurements.  
Results: The present findings demonstrated that before RCA CTO PCI, there was 62% 
agreement between perfusion CMR and FFR (ischemic threshold  0.8) in the assessment of 
LAD ischemia (k = 0.29; fair concordance). At 4 months after revascularization, there was 
77% agreement (k = 0.52; moderate concordance) between the index CMR assessment of 
LAD ischemia and the follow-up LAD FFR. Concordance was improved at a LAD FFR 
ischemic threshold of  0.75. 
Conclusions: In this hypothesis generating study, baseline CMR assessment of LAD 
ischemia correlated better with the 4 months LAD FFR data (threshold  0.8) as compared to 
the FFR measurements taken prior to RCA CTO revascularization.  
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Stress perfusion cardiovascular magnetic resonance (CMR) and fractional flow 
reserve (FFR) are two frequently performed investigations in patients with suspected 
myocardial ischemia. FFR is the current gold standard for invasive functional assessment of 
coronary artery disease of intermediate severity and numerous randomised control trials have 
highlighted its prognostic value [1–3]. Furthermore, research has shown that perfusion CMR 
can accurately diagnose flow-limiting lesions as established by FFR [4–6].  
Multiple studies have revealed that FFR measured in collateral donor vessels, in the 
presence of a chronic total occlusion (CTO), will increase after percutaneous 
revascularisation of the CTO [7–9]. This has important clinical implications; in the recent 
IMPACT-CTO study an increase in the predominant donor vessel FFR at 4 months following 
RCA CTO percutaneous coronary intervention (PCI) led to a functional reclassification in 
18% of lesions at follow-up [7]. Thus, the ability of FFR to identify ischemia in a remote 
artery territory prior to revascularization of a CTO may not be robust. 
Stress perfusion CMR has potential advantages in patients with multivessel disease in 
the presence of a CTO. CMR documents ischemia at the segmental myocardial level, in 
contrast to FFR which determines ischemia in a vascular territory. In the presence of a CTO, 
FFR in a donor artery is influenced not only by the degree of stenosis within the vessel, but 
also by the additional territory supplied by donor vessel collaterals to the CTO region. The 
resultant increase in flow and size of myocardial bed leads to a decrease in FFR and 
potentially a false positive result [8]. This raises the possibility that CMR may be a more 
accurate method of identifying ischemia in remote territories, which in turn could improve 
decision making and outcomes in patients with multivessel disease in the presence of a CTO. 
In the present study an analysis was performed of patients enrolled in the IMPACT-
CTO study to investigate the correlation between baseline stress perfusion CMR and serial 
FFR measurements of LAD remote territory ischemia, taken at baseline in the presence of an 
RCA CTO, and at 4 months after CTO PCI.  
 
METHODS 
The full methodology and results for the IMPACT-CTO study (NCT02643940 
clinical trials.gov number) had been reported previously [7]. In brief, 40 consecutive patients 
with an RCA CTO scheduled for PCI were recruited between October 2015 and November 
2016. Inclusion criteria included symptomatic stable angina, RCA total occlusion of  
3months duration, evidence of myocardial viability ± ischemia on non-invasive testing, and 
visible collateral supply from a contralateral donor vessel. Myocardial viability on CMR was 
defined as < 50% of left ventricular wall hyperenhancement during delayed gadolinium 
imaging. Exclusion criteria included prior coronary artery bypass grafting, > 1 CTO vessel, 
and left main stem disease. The study was approved by the regional ethics committee 
(15/EE/0269) and all patients gave written informed consent. CTO PCI was performed with 
conventional techniques by experienced operators. FFR assessment of remote vessels was 
performed using a pressure wire (Philips Volcano Corporation, San Diego, California) 
before, immediately after, and at 4 months following RCA CTO PCI. Hyperemia was 
attained with an intravenous adenosine infusion administered via a femoral vein at a dose of 
140 mcg/kg/min. Intracoronary nitroglycerine was administered before the physiological 
measurements were acquired. The pressure wire was normalized at the end of the guide 
catheter and passed to the distal aspect of the remote vessel. Two FFR ischemic thresholds of 
 0.8 and  0.75 were used in this sub analysis.  
 
CMR protocol 
Baseline perfusion CMR examinations were undertaken on a subset of patients in the 
IMPACT-CTO study in a 1.5-T scanner (Siemens MAGNETOM Aera). Standard cine 
steady-state-free-processing images were collected in three long axis views and multiple 
short axis slices. Perfusion data was acquired after a 3–4 min adenosine infusion (140 µg–
210 µg/kg/min) and subsequent gadolinium-based contrast agent injection (0.1 mmol/kg at 6 
mL/s). Three slices (basal, mid ventricular, and apical) were then obtained during the first 
pass using a TurboFLASH T1 weighted gradient echo sequence. Rest perfusion images were 
acquired after a period of 10 min and a second bolus of gadolinium contrast agent (0.1 
mmol/kg at 6 mL/s) was administered for the delayed enhancement imaging (assessed at an 
additional 7 min interval).  
 
CMR analysis 
The stress CMR data was analyzed by two experienced readers (SG and JND) blinded 
to the left coronary anatomy and background history. The myocardium was divided using a 
16-segment model (American Heart Association 17-segment model minus the apical cap). 
For the main analysis, the LAD was allocated into segments 1, 2, 7, 8, 13, and 14. The RCA 
was assigned segments 3, 4, 9, 10, and 15 (all patients were RCA dominant) and the left 
circumflex artery was assigned segments 5, 6, 11, 12 and 16. Visual assessment of LAD 
ischemia was determined by consensus agreement by the imaging consultants. Inducible 
perfusion defects were defined as delayed entry of contrast (persisting for more than 5 heart 
beats) in the absence of a scar. The cine sequences and delayed enhancement images were 
assessed simultaneously in order to evaluate for regional wall motion abnormalities and 
infarcted myocardium. A Siemens Syngo.via workstation was used for all analysis. 
 
Reassignment of coronary territories 
To assess the potential impact of variable coronary anatomy, one experienced 
interventional cardiologist (JRD) reviewed all angiographic data included in the sub analysis. 
Each myocardial segment subsequently reassigned (from the 16-segment model) to the 
specific coronary artery subtending that territory. The reassignment of perfusion territories 
was blinded.  
 
Statistical analysis  
Continuous data is presented as means  standard deviation. Categorical data is 
expressed as percentages. Percentage agreement and the kappa statistic was used to assess 
concordance between the perfusion CMR and FFR results (a kappa statistic of +1 signifying 
perfect agreement and a kappa statistic of –1 signifying full disagreement). Statistical 
analysis was performed using GraphPad. 
 
RESULTS 
Twenty-six (26) patients had baseline perfusion CMR testing and follow up remote 
artery FFR measurements at 4 months. All of these individuals were included in the final 
analysis. Average age was 62 ± 9.8 years, 89% were male, 19% had diabetes mellitus, and 
the mean LAD stenosis by quantitative coronary angiography (QCA) was 41% ± 11.1%. 
There was no significant difference in the hemodynamic parameters (central venous pressure, 
mean arterial pressure, and heart rate) during FFR assessment at baseline and follow-up. Full 
demographic data is presented in Table 1.  
 
LAD FFR analysis 
Sixteen (62%) patients had a positive LAD FFR ( 0.8) at baseline, 16 (62%) patients 
had positive LAD FFR ( 0.8) immediately after RCA CTO PCI, and 12 (46%) patients had a 
positive LAD FFR ( 0.8) at 4-month follow-up. 
 
Perfusion CMR analysis 
Perfusion CMR demonstrated RCA territory ischemia in 25 (96%) patients and LAD 
ischemia in 8 (31%) patients. 
 
CMR and FFR concordance in the assessment of LAD ischemia 
There was 62% agreement between baseline CMR and FFR (cut off  0.8) in the 
assessment of LAD ischemia (k = 0.29; fair concordance) prior to RCA CTO PCI. 4 months 
after revascularization, there was 77% agreement (k = 0.52; moderate concordance) between 
the baseline CMR and the follow-up FFR (cut off  0.8) assessment of LAD ischemia. In the 
cases of FFR and CMR discordance was at 4 months; 1 patient was CMR positive and FFR 
negative for LAD ischemia and 5 individuals were FFR positive and CMR negative for LAD 
ischemia (Table 2A).  
5/26 (19%) of patients had a positive LAD FFR ( 0.80) prior to revascularisation and 
a negative LAD FFR (> 0.8) at 4 months. Perfusion CMR was negative for LAD ischemia in 
all of these studies. Examples of concordant and discordant assessments of myocardial 
ischemia are shown in Figures 1 and 2. 
At a lower FFR ischemic threshold of  0.75, there was 85% agreement between 
CMR and FFR in the assessment of LAD ischemia prior to RCA CTO PCI (k = 0.66; good 
concordance). At 4 months following RCA CTO revascularization, there was 81% agreement 
(k = 0.56; moderate concordance) between the baseline CMR and follow up FFR 
measurement of LAD ischemia at that decreased cut off (Table 2B). 
In 22 patients, the LAD was the predominant donor vessel to the RCA CTO territory. 
In these individuals, there was 59% agreement between CMR and FFR (cut off  0.8) in the 
evaluation of LAD ischemia prior to RCA CTO PCI (k = 0.26; fair concordance). At 4 
months following RCA revascularization, there was 72% agreement (k = 0.46; moderate 
concordance) between the baseline CMR and the follow up FFR (cut off  0.8) assessment of 
LAD ischemia. At a lower FFR threshold of  0.75, there was 82% agreement between FFR 
and CMR results (k = 0.61; good concordance) prior to RCA CTO PCI. At 4 months after 
revascularization, there was 77% agreement (k = 0.50; moderate concordance) between the 
baseline CMR and follow up FFR results at this reduced threshold. 
 
Reassignment of coronary territories 
Concordance between CMR and FFR was not affected by the reassignment of 
coronary territories following blinded angiographic review (Table 2A, B). 
 
Collateral vessel regression 
Twenty-two (85%) patients in the sub analysis had evidence of full regression of their 
collateral vessels at follow up. 1 of the 4 patients who had persisting collateral circulation had 
discordant results at 4 months (LAD FFR 0.62 and CMR negative for LAD ischemia). 
 
DISCUSSION 
The major findings of this study are:  
1. There appears to be only fair concordance between perfusion CMR and FFR (ischemic 
threshold  0.8) in the assessment of LAD ischemia prior to RCA CTO revascularisation; 
2. Baseline perfusion CMR appears to correlate better with the FFR assessment (cut off  
0.8) of LAD ischemia at 4 months post RCA CTO PCI as compared to before 
revascularization. This result appears to be due to the ability of a negative baseline CMR to 
identify patients with negative LAD FFR measurements at 4-month follow-up; 
3. Concordance in the assessment of LAD ischemia between perfusion CMR and pre-CTO 
PCI FFR appears to be improved at a lower ischemic threshold (cut off  0.75).  
 
Correlation between CMR and FFR in assessment of LAD ischemia in the context of an 
RCA CTO 
In this sub analysis, there is only fair concordance between perfusion CMR and FFR 
assessment of LAD ischemia prior to RCA CTO PCI (using an FFR threshold of  0.80). 
This result does not appear to be greatly affected by stratifying for the donor vessel or by the 
standard assignment of perfusion territories (i.e. the American Heart Association 17-segment 
model minus the apical cap). The majority of the discordance was due to patients with 
positive LAD FFR lesions and negative perfusion CMR scans (for LAD ischemia).  
These results are similar to prospective studies assessing CMR and FFR in the 
assessment of multivessel disease (MVD). Hussain et al compared the diagnostic accuracy of 
perfusion CMR and FFR in patients with 2- and 3-vessel disease [10]. They found fair 
concordance (at a per vessel basis analysis) between the two modalities and demonstrated 
that CMR either underestimated, or FFR overestimated the number of ischaemic territories in 
33% of cases [10]. A further study by Nakamori et al. [11] again assessed the concordance of 
myocardial perfusion CMR to FFR in patients with both single, and MVD. In their study, 
visual assessment of ischemia by CMR (at a per vessel level analysis) had a sensitivity of 
64% and a specificity of 79% against FFR in 2- or 3-vessel disease [11]. In contrast, in 
patients with single vessel disease, sensitivity of CMR was 83% and specificity was 95% (as 
compared to FFR) [11].  
The etiology of the discordance found in the present sub analysis is likely 
multifactorial but will, in part, be due to inherent limitations of both modalities in individuals 
with a CTO. FFR influenced by myocardial mass subtended by the vessel being interrogated 
[12]. In patients with a collateralized CTO, coronary arteries not only supply their own 
territory, but also the myocardium of the occluded vessel. As such, the use of fractional flow 
to evaluate remote artery ischemia in such patients could have limitations and may lead to 
false positive results.  
Stress perfusion CMR imaging could also have limitations in patients with MVD. 
Firstly, visual assessment of ischemia may be liable the same errors encountered with 
myocardial perfusion imaging (with single-photon emission computed tomography) in MVD. 
Myocardial perfusion imaging (MPI) relies on relative flow heterogeneity and as such, can 
encounter problems with 2- or 3-vessel disease [13]. In these cases, MPI identifies the 
territories subtended by the most severe stenoses and has the potential to disregard perfusion 
defects in other myocardial segments [13]. Conversely, CMR has superior spatial resolution 
(i.e. can distinguish between subendocardial and transmural perfusion deficits) and therefore 
false negative results may potentially be avoided in MVD [11]. Indeed, sub analysis in the 
CE-MARC study revealed that triple-vessel disease was not significantly associated with 
false negative perfusion CMR results [14]. 
In the case where FFR was negative and CMR was positive for LAD ischemia, there 
was no significant epicardial stenosis on quantitative coronary angiography. The CMR result 
may therefore have reflected microvascular ischemia and indeed, it is known that 
microvascular disease can alter the ability of FFR to assess the significance of epicardial 
disease [15]. 
 
Concordance of baseline CMR and serial FFR measurements in patients undergoing RCA 
CTO PCI; ischemic FFR threshold  0.8 
In this small hypothesis generating study, baseline perfusion CMR appears to 
correlate better with FFR in the assessment of LAD ischemia at 4 months post RCA CTO 
PCI as compared to before revascularization. This result appears to be driven by the ability of 
a negative baseline CMR to identify patients with negative LAD FFR measurements at 4- 
month follow-up.  
These are interesting findings as the IMPACT-CTO study concluded that 
interpretation of baseline FFR measurements in vessels providing major collaterals to a CTO 
should be made cautiously [7]. In particular, when their FFR values were close to the 
ischemic cut off, the indices only became reliable after collateral vessel regression (i.e. at 4 
months post PCI in the IMPACT-CTO study) [7]. In clinical practice however, 
revascularization decisions are often guided by index invasive coronary physiology of 
contralateral arteries in CTO patients. A ‘gold standard’ test would correctly identify 
significant epicardial stenoses independent of the altered coronary physiology of a 
collateralized CTO. The current sub analysis suggests that baseline CMR improved 
correlation with invasive data acquired at 4 months and as such, could act as a reliable tool in 
the evaluation of remote artery lesions prior to CTO PCI.   
A recent study by Bucciarelli-Ducci et al. [16] assessed the use of CMR in the 
management of patients with a coronary CTO. As part of their study, remote territory 
myocardial perfusion reserve was measured (MPR) before and after CTO PCI (66% of their 
study patients had MVD) [16]. At 3-month follow-up, there was no significant change in the 
remote territory MPR as compared to the assessment prior to CTO revascularization [16]. 
Another study by Cheng et al. [17] evaluated resting and hyperemic myocardial blood flow 
(MBF) by CMR in individuals undergoing CTO recanalization. They found that the remote 
segment MBF (resting or hyperemic) did not significantly rise at 6 months following CTO 
PCI as compared with baseline [17]. As with the present results, these studies suggest that 
CMR may be able to reliably assess the significance of bystander disease in patients with a 
CTO even prior to CTO revascularization. 
It is unlikely that the failure of collateral regression significantly impacted the current 
results. Ongoing presence of donor vessels arising from the LAD could have affected the 
LAD FFR. In the present study however, only 4 patients had evidence of ongoing collateral 
circulation at 4 months. One of these patients had discordant results and this individual had a 
strongly positive LAD FFR (FFR 0.62) and a negative perfusion CMR for LAD ischemia. As 
such, it was felt that this was a false negative CMR result and not the consequence of residual 
LAD supply to the RCA territory.  
 
Concordance of baseline CMR and serial FFR measurements in patients undergoing RCA 
CTO PCI; ischemic FFR threshold  0.75 
At a lower FFR ischemic threshold of  0.75, the correlation between the two 
assessments of LAD ischemia improved. This is in keeping with a prior study which 
highlighted improved concordance when a reduced ischaemic cut-off for invasive 
physiological measurements was utilised in MVD [10]. The present results suggest that prior 
to CTO revascularization, a lower FFR ischemic threshold may be more appropriate in 
guiding the decision to revascularize the donor vessel. 
 
Limitations of the study 
This study has a number of limitations including its small number of subjects. 
Another main limitation is its design. Although CMR readers were blinded to the left 
coronary anatomy, they were aware that each patient had an RCA CTO. As such, there was a 
potential bias towards assessing for inferior ischemia. In addition, undertaking a repeat CMR 
at 4 months (to mirror the follow-up invasive measurements) would have allowed for a  
much improved analysis on the use of perfusion CMR in this cohort. Indeed, there are major 
limitations in comparing baseline CMR scans to FFR data collected 4 months following the 
index non-invasive test and a PCI procedure. As mentioned above however, a number of 
studies have performed serial perfusion CMRs in CTO patients [16, 17]. Interestingly, these 
studies did not find evidence of significant variation in remote territory ischemia following 
CTO PCI [16, 17]. Therefore, it may be fair to assume that the perfusion CMR appearance in 
the LAD territory would not have changed on follow-up imaging in the IMPACT-CTO 
cohort, in the absence of further revascularization. As such, baseline perfusion CMR 
examinations herein, may be a reliable comparator against the serial FFR measurements.  
A further potential limitation is that qualitative assessment of CMR ischemia was 
performed in the current analysis. This does have the disadvantage of requiring a normal 
reference area of myocardium for visual comparison. Utilising a semiquantitative, or 
quantitative, approach to CMR analysis would have potentially provided a more robust 
assessment of inducible perfusion deficits. Finally, 2-dimensional perfusion CMR (as 
conducted in the present study) is limited by a lack of total myocardial coverage (e.g. 
conventionally three non-contiguous short axis myocardial slices, excluding the apical cap) 
[18]. Three-dimensional perfusion CMR is an exciting area of development which allows for 
whole-heart coverage and has been shown to have good diagnostic accuracy as compared to 
FFR [19].  
Further studies incorporating all of the above methodological changes would enhance 
the strength of the ensuing results. 
 
CONCLUSIONS 
The IMPACT-CTO CMR analysis highlights the potential use of CMR in the work up 
of patients with borderline LAD lesions and an RCA CTO. Larger prospective studies are 
needed to assess whether baseline perfusion CMR is able to reliably act as a gatekeeper for 
revascularization in patients with LAD disease and an RCA CTO. 
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 Figure 1. Concordant stress perfusion cardiovascular magnetic resonance (CMR) and fractional flow reserve 
(FFR) results. CMR imaging (left panel) demonstrating a perfusion defect in the left anterior descending (LAD) 
artery (e.g. white arrow) and right coronary artery (RCA; e.g. dashed arrow) territories. Coronary angiogram 
(right panel) demonstrating concordant findings with a severe LAD lesion (FFR 0.58 at baseline and 0.33 at 4 
months; black arrow) and an occluded RCA. 
 
 













Figure 2. Discordant stress perfusion cardiovascular magnetic resonance (CMR) and baseline fractional flow 
reserve (FFR) result. CMR imaging (left panel) demonstrating a perfusion defect in the right coronary artery 
(RCA) territory (e.g. black arrow). Coronary angiogram (right panel) demonstrating discordant findings with an 
occluded RCA and a left anterior descending (LAD) with an FFR of 0.78 at baseline and 0.82 at 4 months 
following RCA percutaneous intervention. 
 
 
Table 1. Baseline demographic and angiographic data. 
     N (%) or mean ± SD 
Demographic (n = 26) 
Male     23 (85%) 
Age [years]    62 ± 9.8 
Previous MI    17 (65%) 
Previous PCI    10 (38.5%) 
Hypertension    17 (65.4%) 
Hypercholesterolemia   20 (76.9%) 
Diabetes mellitus   5 (19.2%) 
Current smoker   5 (19.2%) 
Angina duration [months]  37.15 ± 52.48 
Angina CCS class (1/2/3/4)  3 (12%)/10 (38%)/13 (50%)/0 (0%) 
Estimated CTO duration [weeks] 224.38 ± 392.16 
Angiographic details 
RCA CTO    26 (100%) 
LAD stenosis on QCA [%]  40.91 ± 11.07 
 
SD — standard deviation; MI — myocardial infarction; PCI — percutaneous coronary intervention; CCS — 
Canadian Cardiovascular Society; CTO — chronic total occlusion; RCA — right coronary artery; LAD — left 








Table 2. A. Concordance between baseline perfusion cardiovascular magnetic resonance 
(CMR) and serial fractional flow reserve (FFR) measurements (at an ischemic threshold of  
0.80); B. Concordance between baseline perfusion CMR and serial FFR measurements (at an 
ischemic threshold of  0.75). The results were not affected by reassignment of coronary 
territories following blinded angiographic review. 
 
FFR results (threshold of  0.80) 
Prior to RCA CTO PCI 4 months following RCA CTO PCI 
A. CMR result   LAD FFR negative LAD FFR positive LAD FFR negative LAD FFR positive 
Negative for LAD ischemia  9  9  13  5 
Positive for LAD ischemia  1  7  1  7 
FFR results (threshold of  0.75) 
Prior to RCA CTO PCI 4 months following RCA CTO PCI 
B. CMR result   LAD FFR negative LAD FFR positive LAD FFR negative LAD FFR positive 
Negative for LAD ischemia  15  3  15  3 
Positive for LAD ischemia  1  7  2  6 
 
RCA — right coronary artery; CTO — chronic total occlusion; PCI — percutaneous coronary intervention; LAD — left anterior descending 
artery 
 
